Invesco’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-121,837
| Closed | -$5.11M | – | 3777 |
|
|
2024
Q3 | $5.11M | Sell |
121,837
-11,857
| -9% | -$498K | ﹤0.01% | 2202 |
|
|
2024
Q2 | $4.87M | Buy |
133,694
+11,330
| +9% | +$412K | ﹤0.01% | 2192 |
|
|
2024
Q1 | $6.23M | Buy |
+122,364
| New | +$6.23M | ﹤0.01% | 2086 |
|
|
2022
Q2 | – | Sell |
-562
| Closed | -$21K | – | 4070 |
|
|
2022
Q1 | $21K | Buy |
562
+4
| +0.7% | +$149 | ﹤0.01% | 3951 |
|
|
2021
Q4 | $53K | Sell |
558
-234
| -30% | -$22.2K | ﹤0.01% | 3938 |
|
|
2021
Q3 | $115K | Buy |
792
+88
| +13% | +$12.8K | ﹤0.01% | 3879 |
|
|
2021
Q2 | $130K | Buy |
+704
| New | +$130K | ﹤0.01% | 3830 |
|
|
2020
Q3 | – | Sell |
-1,200
| Closed | -$399K | – | 3634 |
|
|
2020
Q2 | $399K | Buy |
1,200
+107
| +10% | +$35.6K | ﹤0.01% | 3221 |
|
|
2020
Q1 | $249K | Buy |
+1,093
| New | +$249K | ﹤0.01% | 3301 |
|